Hydase is a Infiltration; Interstitial; Intramuscular; Intraocular; Retrobulbar; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Akorn, Inc.. The primary component is Hyaluronidase.
Product ID | 17478-560_d0aefc9f-b2fb-4490-8642-c5a70f0a4a54 |
NDC | 17478-560 |
Product Type | Human Prescription Drug |
Proprietary Name | Hydase |
Generic Name | Hyaluronidase |
Dosage Form | Injection, Solution |
Route of Administration | INFILTRATION; INTERSTITIAL; INTRAMUSCULAR; INTRAOCULAR; RETROBULBAR; SUBCUTANEOUS |
Marketing Start Date | 2015-11-05 |
Marketing Category | NDA / NDA |
Application Number | NDA021716 |
Labeler Name | Akorn, Inc. |
Substance Name | HYALURONIDASE |
Active Ingredient Strength | 150 [USP'U]/mL |
Pharm Classes | Endoglycosidase [EPC],Glycoside Hydrolases [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2015-11-05 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA021716 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2015-11-05 |
Marketing End Date | 2015-12-01 |
Marketing Category | BLA |
Application Number | BLA021716 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2015-11-05 |
Marketing End Date | 2015-12-01 |
Marketing Category | BLA |
Application Number | BLA021716 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2015-11-05 |
Marketing End Date | 2015-12-01 |
Ingredient | Strength |
---|---|
HYALURONIDASE | 150 [USP'U]/mL |
NDC | Brand Name | Generic Name |
---|---|---|
17478-560 | Hydase | Hyaluronidase |
0548-9090 | AMPHADASE | hyaluronidase |
51662-1555 | HYALURONIDASE | HYALURONIDASE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
HYDASE 86813398 not registered Dead/Abandoned |
Akorn, Inc. 2015-11-09 |
HYDASE 76330151 not registered Dead/Abandoned |
Purified Proteins, Inc. 2001-10-26 |